Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

TB Alliance

Public_Health

Public Health Video Recap—November 21, 2025

This week’s Public Health news brings you late-stage trial wins, early…

Respiratory

Respiratory Today—November 21, 2025

Discover what’s new in Respiratory this week including regulatory approvals,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Conference Previews
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: WellBeam $10M Series A
Public Health Video Recap—November 21, 2025
Public Health Today—21 November, 2025
Respiratory Today—November 21, 2025
Vaccines Today—November 21, 2025

Tags

ActRIIB pathway adolescents Aera Therapeutics Agomab allergy American Heart Association Anixa Biosciences Artificial sweeteners Artios Association of Migraine Disorders Azercell Bill Gates BioPharma Corporate Venture Capital CABINET trial CPMS CryoTherapeutics EJPC Elfabrio (pegunigalsidase alfa) elinzanetant ELS System Er-Kim Eric Horvitz Evaxion A/S HDR IL-2 INDUKINE Invest-NL investor relations lurbinectedin MHRA Neurodevelopmental disorders Nilo Therapeutics Novo Nordisk Wegovy NPM1-m AML Opus Genetics PAD Philips MCOT ePatch ReCode Therapeutics refractory angina respiratory clinical trials respiratory syncytial virus SeCys-tRNA SMOC1 TAVIPILOT Soft Theranica Xgeva

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: WellBeam $10M Series A
Public Health Video Recap—November 21, 2025
Public Health Today—21 November, 2025
Respiratory Today—November 21, 2025
Vaccines Today—November 21, 2025

TAGS

ActRIIB pathway adolescents Aera Therapeutics Agomab allergy American Heart Association Anixa Biosciences Artificial sweeteners Artios Association of Migraine Disorders Azercell Bill Gates BioPharma Corporate Venture Capital CABINET trial CPMS CryoTherapeutics EJPC Elfabrio (pegunigalsidase alfa) elinzanetant ELS System Er-Kim Eric Horvitz Evaxion A/S HDR IL-2 INDUKINE Invest-NL investor relations lurbinectedin MHRA Neurodevelopmental disorders Nilo Therapeutics Novo Nordisk Wegovy NPM1-m AML Opus Genetics PAD Philips MCOT ePatch ReCode Therapeutics refractory angina respiratory clinical trials respiratory syncytial virus SeCys-tRNA SMOC1 TAVIPILOT Soft Theranica Xgeva

Consulting Services
For Investors
- Lucid Diligence Briefs
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy